Skip to main
STAA
STAA logo

STAAR Surgical (STAA) Stock Forecast & Price Target

STAAR Surgical (STAA) Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 31%
Buy 0%
Hold 62%
Sell 8%
Strong Sell 0%

Bulls say

Staar Surgical Co. is well-positioned for sustained above-market volume growth, particularly with the anticipated domestic launch of the EVO lens and increased adoption both domestically and internationally. The company is actively streamlining its operations to enhance revenue growth and improve its cost structure, which suggests a commitment to financial discipline and strategic investment. Furthermore, strong bull case assumptions project revenue growth exceeding 10%, supported by improved operating expense leverage, indicating the potential for significant earnings growth and margin improvements.

Bears say

The analysis indicates a negative outlook for Staar Surgical's stock based on several fundamental factors. Revenue growth is projected to remain flat or decline, particularly due to weaknesses in the Chinese market and challenges in the broader macroeconomic environment, which may significantly impact sales. Additionally, the company faces risks related to customer concentration, disappointing product launches, competition from lower-cost alternatives, and an increasing prevalence of myopia control products, all of which contribute to concerns about future financial performance.

STAAR Surgical (STAA) has been analyzed by 13 analysts, with a consensus rating of Hold. 31% of analysts recommend a Strong Buy, 0% recommend Buy, 62% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About STAAR Surgical (STAA) Forecast

Analysts have given STAAR Surgical (STAA) a Hold based on their latest research and market trends.

According to 13 analysts, STAAR Surgical (STAA) has a Hold consensus rating as of Aug 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $49.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $49.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

STAAR Surgical (STAA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.